id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-018770-uy76mc2j	Connelly-Smith, Laura S.	Donor Evaluation for Hematopoietic Stem and Progenitor Cell Collection	2019-11-28		.txt	text/plain	9144	439	43	With the increasing incidence of hematopoietic allogeneic cell transplantation (allo-HCT), the importance of securing a cellular product, safely from a donor, and ensuring that the product is without additional risk to the recipient, continues to be of paramount importance. Various registries have developed HPC donor-screening questionnaires and their use recommended, to elicit medical history and to identify high-risk behaviors associated with risk of disease transmission (AABB n.d.-a; National Marrow Donor Program 2002) . One such questionnaire that is freely available is the hematopoietic progenitor cell (HPC), Apheresis and HPC, Marrow Donor History Questionnaire (DHQ) (Appendix 4.1) developed by the AABB Inter-organizational DHQ-HPC Task Force to provide establishments with a standardized tool to screen allogeneic HPC donors for communicable disease risk factors in accordance with requirements of the FDA, AABB, FACT, and the NMDP (AABB n.d.-a). Areas to be evaluated and documented during history and physical examination (H&P) of potential allogeneic/syngeneic donors of peripheral blood stem cells or marrow.	./cache/cord-018770-uy76mc2j.txt	./txt/cord-018770-uy76mc2j.txt